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INTRODUCTION Glaucoma is one of the leading causes of irreversible blindness throughout the
world. WHO statistics indicate that glaucoma is the second leading cause of blindness globally after
cataracts. [ 1]It has been estimated that about 12 milion people are affected by glaucoma in India and
the majority of them are undiagnosed. [2] In Southern India, the prevalence of glaucoma has been
estimated to be around 2.6% & 90% of these cases have never been diagnosed before, compared to
50% previously undiagnosed in European countries. [1] Glaucoma is defined as a chronic
progressive optic neuropathy, caused by various ocular conditions which lead to damage of the optic
nerve with loss of visual...
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ABSTRACT 
 
AIM: To compare the central corneal thickness in individuals with and 
without pseudo exfoliation syndrome. 
METHODS: This was a hospital based cross sectional, comparative study. 
50 individuals with unilateral or bilateral pseudo exfoliation syndrome 
(study group) and individuals without pseudo exfoliation syndrome (control 
group), both without any corneal pathology and glaucoma were included in 
the study. The CCT was measured by an ultrasonic pachymeter. The IOP 
was measured by Goldmann applanation tonometer and was adjusted for the 
CCT values. 
 RESULTS: There was no significant correlation between CCT, age and 
gender. The mean CCT was 0.515± 0.07 mm in the control group and 0.501 
mm + 0.07 mm in study group (P value=0.001). The mean IOP was almost 
similar in both groups. However, the IOP after CCT adjustment was 
significantly higher in the study group than the control group. 
CONCLUSION: The mean CCT was significantly lower in the individuals 
with pseudoexfoliation than in individuals without pseudo exfoliation. There 
was no significant difference in the CCT between the eye with PEXF and its 
fellow eye in unilateral pseudo exfoliation syndrome. 
 Key words: Central corneal thickness, pseudo exfoliation syndrome. 
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INTRODUCTION 
Glaucoma is one of the leading causes of irreversible blindness 
throughout the world. WHO statistics indicate that glaucoma is the second 
leading cause of blindness globally after cataracts. [1] It has been estimated that 
about 12 million people are affected by glaucoma in India and the majority of 
them are undiagnosed. [2] 
In Southern India, the prevalence of glaucoma has been estimated to be 
around 2.6% and 90% of these cases have never been diagnosed before, 
compared to 50% in European countries. [1] 
Glaucoma is defined as a chronic progressive optic neuropathy, caused 
by various ocular conditions which lead to damage of the optic nerve with loss 
of visual function, the most common risk factor being an increased intra ocular 
pressure. [3] 
Being an important risk factor, the measurement of IOP is an 
indispensable diagnostic tool in the evaluation of glaucoma. An elevated IOP is 
the first alarming sign indicative of the patient being affected by or is at risk of 
developing glaucoma. Rather than a diagnostic tool, IOP measurement plays an 
important role in the classification of glaucoma and acts as an important guide 
  
to plan the management. An accurate measurement of IOP is required to 
determine the target pressure to be achieved by treatment, to monitor the 
response to treatment, to determine the adequacy or a need for change of 
treatment. Being easily measurable and modifiable, measurement of IOP 
becomes indispensable in the diagnosis, management and follow up of 
glaucoma. 
Goldmann’s applanation tonometry (GAT) is the gold standard technique 
of measuring the IOP. [4] IOP measurements by GAT are affected by various 
factors among which Central Corneal Thickness is considered the most 
important. [5,6] CCT which was initially presumed to be fixed and constant, is 
now found to be affected by various factors such as race, age, etc.[7,8,9,10] The 
variations in the CCT significantly influence the IOP measurements by GAT.  
GAT tends to overestimate the IOP in thicker corneas and underestimates the 
IOP in thinner corneas. [11, 12] 
 Apart from the physiological and demographic factors which influence 
the CCT, certain pathological conditions too significantly affect the CCT. 
Various studies have shown that CCT varies in different types of glaucoma. The 
CCT was found to be thicker in patients with ocular hypertension and thinner in 
cases of normal tension glaucoma, primary open angle glaucoma and pseudo 
exfoliation glaucoma.[13,14] While thicker corneas lead to over diagnosis of 
  
glaucoma, thinner corneas carry an increased risk of delayed diagnosis due to 
underestimation of IOP. 
Measurement of CCT, therefore, has become an important diagnostic tool 
in the evaluation of glaucoma. Apart from this, CCT plays an important role in 
predicting the risk of developing glaucoma in predisposed individuals and 
determining its progression in established cases. Thinner corneas serve as an 
independent risk factor for the development of glaucoma compared with thicker 
corneas. [15] Thus, eyes with thinner corneas are not only predisposed to 
glaucoma but also carry a risk of underestimation of IOP.  
Various studies have shown that CCT is thinner not only in individuals 
with pseudo exfoliation Glaucoma [16] but also in individuals with Pseudo 
exfoliation syndrome without glaucoma. [17] Presence of pseudo exfoliation, an 
established risk factor, when coupled with a thinner CCT confers a greater risk 
for the development of secondary open angle glaucoma. This, along with a 
delay in diagnosis due to underestimation of the IOP, worsens the prognosis of 
pseudo exfoliation glaucoma. 
Hence, the measurement of CCT, though mandatory in all cases of 
glaucoma, special emphasis must be given in those who are at an increased risk 
of developing glaucoma such as Pseudo exfoliation syndrome to facilitate early 
  
diagnosis, an appropriate management by determining the exact target pressure 
to be attained and to ensure the adequacy of treatment. 
  
  
PSEUDOEXFOLIATION SYNDROME 
Pseudoexfoliation syndrome was first described by Lindberg in 1917. [18]  
The prevalence of pseudo exfoliation differs in different population. The 
prevalence of PEXF in South India is around 6%. [19] The prevalence was found 
to increase with age and was greater in males. [19, 20] Pseudo exfoliation 
syndrome rarely occurs below the age of 50 years.  
 The presence of exfoliative material in autopsy specimens of the heart, 
lung, liver and kidney in patients with ocular PXS suggested that ocular PXS 
syndrome is part of a general systemic disorder.[21] PXS is also found to be 
associated with cardiovascular diseases, cerebral disorders, Alzheimer disease 
and acute cerebrovascular accidents.[22]  
 Two single nucleotide polymorphisms in the lysyl oxidase-like 1 
(LOXL1) gene have been recently identified as strong genetic risk factors for 
the development of Pseudo exfoliation syndrome and pseudo exfoliation 
glaucoma. [23, 24] 
 Pseudo exfoliation occurs due to the progressive accumulation or 
deposition of abnormal extracellular fibrillo granular material in almost all 
tissues of the anterior segment of the eye. The production of the exfoliation 
material is attributed to an increase in the elastic micro fibril components and 
  
imbalance between the matrix metalloproteinases and their inhibitors in the 
ocular tissues [25, 26, 27] such as the lens epithelium, trabecular meshwork, iris, 
ciliary processes, conjunctiva and periocular tissue.[28] The exfoliative material 
gets deposited on the corneal endothelium, trabecular meshwork, iris, pupillary 
margin, anterior lens capsule, ciliary body and ciliary zonules resulting in 
various pathologic alterations in the eye. Ultra structural changes have also 
been documented in the lens capsule, zonules, iris tissue, ciliary body, 
trabecular meshwork and the conjunctival vessels. [29] 
 Pseudo exfoliation is diagnosed by the presence of white, flaky, dandruff 
like, fibrillo granular material on the pupillary margin or the anterior capsule of 
the lens. A characteristic “three-ring sign” is frequently noted on the anterior 
lens capsule after pupillary dilatation. It comprises of three zones, a central 
zone of about 3 mm with visible exfoliation material, a middle clear zone and a 
peripheral cloudy ring. The central zone is well demarcated with curled edges. 
The middle clear zone is due to rubbing off of the pseudo exfoliative material 
by the posterior surface of the iris. This leads to loss of iris pigment resulting in 
trans-illumination defects.  
 Pseudo exfoliation in the anterior chamber angle is evident in gonioscopy 
by the presence of patchy pigment deposition on the trabecular meshwork 
which is more marked in inferior quadrant and the presence of Sampolesi’s line. 
  
 The presence of pseudo exfoliation affects every part of the anterior 
segment and results in the following complications: 
Corneal endothelial decompensation:  
 Electron microscopic and In Vivo Confocal microscopic studies have 
demonstrated large clumps of pseudoexfoliation material adherent to the 
corneal endothelium and a resultant decrease in the endothelial cell density. [30] 
The endothelial cell loss is attributed to the hypoxic changes in the anterior 
chamber, accumulation of extracellular matrix and fibroblastic changes in the 
endothelium. [25, 26, 27] In addition, breakdown of the blood aqueous barrier and 
the resultant change in aqueous humor affect the cellular metabolism leading to 
endothelial cell loss. [31, 32] 
Decreased Corneal Sensitivity: 
 The deposition of the exfoliative material and infiltration by             
dendritic cells within the sub basal nerve plexus results in decreased corneal 
sensitivity. [30, 31] 
Thinning of Central Cornea: 
In Vivo Confocal Microscopy demonstrated the presence of pseudo 
exfoliation material in the anterior stromal layers of the cornea and a reduction 
  
in the stromal cell densities. This was suggested to be the cause of thinner CCT 
in eyes with PEXF. The thinning was presumed to be due to apoptosis of the 
keratocytes. [30] 
Poor dilatation of the pupil: 
PEXF causes atrophy of the dilator papillae resulting in poor pupillary 
dilatation. [34] 
Cataract & Cataract Surgery: 
Individuals with PEXF are more prone to develop cataracts and are at 
higher risk of various complications during cataract surgery. Poor dilatation of 
the pupil and synechiae between the iris and the peripheral anterior capsule 
make the surgery difficult. The ciliary zonules are weakened due to PEXF and 
may result in zonular dehiscence and nucleus drop. The incidence of posterior 
capsular rent and vitreous loss is also high in eyes with PEXF. [35] 
The weakening of ciliary zonules may result in spontaneous subluxation 
or dislocation of the lens.  
Impaired tear film stability:  
Significantly lower Schirmer’s test and tear film BUT values have been 
observed in the eyes with PEXF than the eyes without PEXF. The reason for the 
  
same whether due to conjunctival involvement or any other cause is still under 
research. [36] 
Melanin dispersion: 
PEXF causes focal disintegration of iris pigment epithelial cells resulting 
in pigment dispersion. It commonly occurs after pupillary dilatation. [34] 
Glaucoma: 
20% of eyes with PXS are associated with narrow anterior chamber 
angles. They are at risk of developing angle closure glaucoma. [37] Subluxation 
and dislocation of lens may also result in secondary angle closure glaucoma. 
However, this is relatively rare. 
Pseudo exfoliation is the most common cause of secondary open angle 
glaucoma. The presence of PEXF confers a greater risk of developing 
glaucoma. The incidence of glaucoma in individuals with PEXF ranges from 
9% to 35%. The risk of developing glaucoma is 6 to 10 times higher in the eyes 
with PXS than those without PXS. [38, 39, 40] The exfoliative material produced by 
trabecular endothelial cells and other ocular tissues accumulates in the 
trabecular spaces and causes collapse of the Schlemm’s canal resulting in 
decreased aqueous humor outflow thereby increasing the IOP. [41] 
  
PEXG carries a worse prognosis than POAG because most patients 
present with advanced optic nerve damage and severe visual field defects. The 
response to medication is also poor. Retinal vein occlusion has also been 
associated with pseudoexfoliation glaucoma, which further makes the prognosis 
more guarded than POAG. [42, 43] 
The advanced stage at presentation is attributed to the underestimation of 
the IOP by GAT because of a thinner CCT. In addition, being an independent 
risk factor for the development of glaucoma, [15] thinner CCT increases the 
susceptibility to rapid progression of the disease. The control achieved by 
treatment is also an apparent one because the IOP is underestimated and the 
disease keeps progressing with an apparently controlled IOP.  
These hazards can be minimized by measuring the CCT in individuals 
with PXS in order to identify those with thinner corneas who are at increased 
risk of developing glaucoma and to ensure detailed evaluation and periodic 
follow up. The IOP must also be adjusted according to the CCT to obtain the 
true IOP values to facilitate early diagnosis and ensure the adequacy of 
treatment. 
 
 
  
Figure 1.Pseudo exfoliation in pupillary margin 
 
 
Figure 2. Pseudoexfoliation over anterior lens capsule 
 
 
  
Figure 3. In Vivo Confocal Microscopic view of pseudoexfoliation material 
 
3a. Over the corneal endothelium        3b. Within subbasal Nerve plexus 
 
 
 
 
 
 
Figure 4. Sampolesi’s line on gonioscopy 
 
 
  
  
CENTRAL CORNEAL THICKNESS 
Central corneal thickness is one of the very important parameters 
significantly affecting the IOP measurements by GAT and pulsatile ocular 
blood flow tonograph. [44]The CCT was initially found to be constant in all 
individuals. Various studies have found that the CCT is highly variable and is 
affected by a wide variety of factors: 
1. Ethnicity:  
CCT shows significant variations in different populations. African-
Americans were found to have thinner CCT than Caucasians, Asians and 
Hispanic population. [7, 45] CCT was found to vary even within the Asian sub-
populations. [46]The average CCT in Indian population was found to be 
0.520mm. [47] Another study showed that the mean CCT in normal Indian 
population was about 0.545mm. [48] 
2. Age:  
CCT is found to decrease with increasing age. However, few studies have 
shown that no significant correlation exists between age and CCT.  [49, 50] 
 
 
  
3. Sex:  
 No definite correlation is found to exist between CCT and sex. Various 
studies have showed that CCT may be higher, [8] similar [51] or lower [52] in 
males than females. 
4. Corneal curvature: 
CCT is found to be thinner in eyes with steeper corneas than flat corneas. 
[53] 
  Few studies, however, have reported that no significant correlation exists 
between CCT and corneal curvature. [54] 
5. Refractive error: 
Myopes are found to be associated with thinner corneas. [55, 56] 
6. Ocular surgery:  
Orb scan tends to underestimate the CCT measurements after refractive 
surgery. [57] Intraocular surgeries like cataract extraction are also found to cause 
thinning of the central cornea. [58] 
7. Corneal pathology: 
Fuchs’s endothelial dystrophy [59] is associated with thicker CCT. The 
presence of corneal edema tends to underestimate the CCT. [57] 
  
8. Glaucoma: 
Ocular hypertensives are found to be associated with thicker CCT while 
normal tension glaucoma is associated with thinner corneas. POAG, PEXG are 
also found to have thinner corneas. [13, 14] 
9. Pseudoexfoliation: 
Eyes with PEXF are associated with thinner CCT than those without 
PEXF. [17] 
10. Systemic diseases: 
Diabetes mellitus is associated with increase in CCT. This is attributed to 
the increased collagen cross linking in the corneal stroma. [60, 61] Chronic Kidney 
disease, metabolic syndrome and higher body mass index are also found to be 
associated with thicker CCT. [62] 
Few other ocular parameters such as axial length, retinal nerve fiber layer 
thickness, optic disc size, cup disc ratio have also been found to have significant 
relationship with CCT. [63, 64] 
 
 
  
SIGNIFICANCE OF CCT IN GLAUCOMA: 
 The role of CCT in IOP measurement by GAT has been well emphasized 
by various studies. [5, 6] Measurement of CCT followed by adjustment of IOP 
helps in classifying the patients as ocular hypertension, glaucoma suspects and 
normal tension glaucomas. [13, 14] Few studies have demonstrated that the CCT 
measurement has a significant influence on glaucoma management and has led 
to significant modifications in the treatment options. [65]   
 CCT itself is found to act as an independent risk factor in predicting          
the risk of development and the likelihood of progression of glaucoma. [15]          
The Ocular Hypertension Treatment Study suggested that thinner CCT is a 
strong predictor of development of glaucoma in eyes with ocular hypertension.  
[66] Role of CCT as an independent risk factor for development of glaucoma is 
explained by the fact that sclera is anatomically continuous with the cornea 
anteriorly and the lamina cribrosa of the optic nerve head posteriorly               
and therefore changes in the corneal thickness may significantly affect the optic 
disc too.  
 The inferior and superior areas of the optic disc are associated with a 
higher lamina cribrosa pore-to-disc area ratio and a thinner connective tissue 
support and hence are susceptible to more axonal damage produced by increase 
  
in IOP. Whereas, with a decrease in disc size, the pore-to-disc area ratio also 
decreases, with a greater connective tissue support. [67, 68, 69] The deformability 
of a disc with smaller radius is less than that of one with larger radius 
(Laplace’s law). Therefore, for a given IOP, a disc of smaller size experiences 
less glaucomatous damage than a disc of larger size. 
 Various studies have shown that CCT has a negative correlation with 
optic disc area. [15, 70] Thinner CCT is associated with larger disc size and 
decreased connective tissue support at the lamina cribrosa leading to increased 
deformability. Such eyes are more prone for glaucomatous damage than eyes 
with thicker corneas. 
MEASUREMENT OF CCT: 
Optical pachymetry: 
Optical pachymetry measures the distance between the Purkinje Sanson 
images formed by the anterior and posterior surfaces of the cornea. It employs 
technique of optical doubling. An image doubling prism mounted on a slit lamp 
biomicroscope forms two images of the cornea which are viewed through a 
fixed and rotatable glass plate. The latter is adjusted until the endothelial 
surface of one image is aligned with the epithelial surface of the other. The 
corneal thickness is directly measured from a calibrated scale. [71] 
  
Ultrasound pachymetry: 
This is a dry contact technique. Sound waves are emitted by a 
piezoelectric crystal and delivered with a probe. Based on the time required for 
the sound waves to pass through the cornea and the velocity of sound in the 
cornea (estimated to be 1630m/sec), the CCT is measured at a frequency of 10 
to 20 MHz This is the most common method used, fast and simple to perform. 
Ultrasound pachymeters are portable, accurate and highly reliable. Corneal 
thickness as low as 125 microns can be measured.  They have an inbuilt 
algorithm for adjustment of the IOP measured by applanation according to the 
CCT. They are provided with a printer which enables easy documentation. [57] 
However, this underestimates CCT in edematous corneas. 
Ultrasound Biomicroscopy (UBM): 
UBM (50 MHz) and very high frequency ultrasound (70 MHz) require 
water bath to measure CCT and discern the sublayer details. [57] 
Specular microscopy: 
Specular microscopy works on optical focusing technique. The reading is 
set at zero by focusing the interface between the contact element and the 
epithelial layer. Once the endothelium is focused, the CCT is automatically 
  
displayed. This technique tends to overestimate the CCT compared with other 
techniques. [57] 
Orb scan: 
This non-contact method scanning slit based corneal topography 
incorporates corneal thickness measurement too. [57] 
Optical Coherence tomography (OCT): 
OCT measures CCT based on optical interferometry. Measurements by 
OCT are thinner than ultrasound pachymetry. It delineates sub layer details and 
can measure CCT where ultrasound pachymetry is unable to measure. [57] 
Optical Low Coherence Reflectometry (OLCR): 
OLCR measures CCT at 18 MHz using infrared radiation. This is 
incorporated into an excimer laser platform to measure CCT during corneal 
ablation. [57] 
Confocal Microscopy Through Focusing:  
CMTF measures CCT by through-focusing a confocal microscope 
through the thickness of cornea. It also displays the sub layer details and 
corneal microbiological processes. It cannot be used in eyes with corneal 
opacities. [57] 
  
Laser Doppler interferometry: 
This non-contact technique employs dual beam infra-red laser Doppler 
interferometry for measuring CCT. [57] 
  
 Figure 5
Figur
. Principle of Optical Pachymetry 
e 6. Ultrasound Pachymeter 
 
 
 
 
 
  
Figure 7. Calibrations in Ultrasound Pachymeter 
 
 
Figure 8. Corneal thickness measurement in UBM 
 
 
 
  
Figure 9. Corneal thickness measurement in anterior segment OCT 
 
Figure 10. Orbscan 
 
 
  
REVIEW OF LITERATURE 
Studies by Wessels et al. [4] and various others proved that Goldmann 
applanation tonometry is the most accurate technique for the measurement of 
IOP.  
Goldmann et al. [72] demonstrated the influence of central corneal 
thickness in the measurement of IOP by GAT. However, they suggested that 
changes occurring in the CCT significant enough to alter the IOP readings 
occurred very rarely. 
Hansen et al. [73] established that the CCT has a definite correlation with 
the IOP measurement by GAT. This was also proved by Ehlers  et al. ,[5]  
Whitacre et al. [6] and various other studies.  
Doughty et al. [12] established the fact that GAT overestimates the IOP in 
thicker corneas and underestimates the IOP in thinner cornea. The same was 
proven by studies by Kohlhaas et al. [11] and various others.  
 Gordon et al. [66] in ‘The Ocular Hypertension Treatment Study’ reported 
the fact that CCT serves as an independent risk factor for the progression of 
ocular hypertension to primary open angle glaucoma. They found that thinner 
  
CCT was a powerful predictor of the development of glaucoma in ocular 
hypertension. 
 Herndon et al. [15] suggested that CCT was a powerful parameter in 
determining the severity of glaucoma damage at the time of presentation. 
 Christoph et al [74] reported that a significant negative correlation existed 
between central corneal thickness and cup disc ratio. A similar correlation was 
demonstrated by Memon et al. [75] They established that thinner corneas had 
advanced disease at presentation with an increased cup-disc ratio. The same 
was in accordance with the study by Tharwat et al. [76]  Iyamu et al. [77] 
suggested that CCT was a better predictor than IOP in identifying individuals at 
higher risk of developing POAG.  
 Pakravan et al. [70] reported that eyes with thinner corneas were 
associated with larger and more deformable optic discs increasing their 
susceptibility to glaucomatous damage by increased IOP.  
 CCT, apart from being an important parameter in the estimation of IOP, 
serves as a powerful factor in predicting the development and progression of 
glaucoma. A number of studies have been done to assess the thickness of 
cornea in various types of glaucoma such as primary open angle glaucoma, 
primary angle closure glaucoma, normal tension glaucoma, pseudo exfoliation 
  
glaucoma, ocular hypertension and conditions like Pseudo exfoliation syndrome 
where there is an increased risk of glaucoma. Few of such studies are discussed 
below. 
 Kenji Inoue et al examined the morphology of corneal endothelium and 
the central corneal thickness in the eyes of patients with Pseudoexfoliation 
syndrome (PXS).The central corneal thickness was measured in 26 eyes with 
PXS (7 eyes o glaucoma patients  and 19 eyes of patients without glaucoma) in 
21 patients and in 30 patients without PXS, who served as the control group. 
The corneal endothelial morphology and central corneal thickness (CCT) were 
compared between the two groups. It was found that the central cornea was 
significantly thinner in the eyes with PXS (0.529 + 0.31 mm) than in the eyes 
without PXS (0. 547 + 0.28 mm) (P= .03). However, it was found that there 
was no significant difference in the CCT between the eyes with and without 
glaucoma in tne PXS group. [78] 
 Mohammad Ali Zare et al. in their presentation “Central Corneal 
Thickness, Corneal Endothelial Cell Density, and Lens Capsule Thickness in 
Normotensive Patients with and without Pseudoexfoliation Syndrome” 
concluded that the mean central corneal thickness in the Pseudoexfoliation 
syndrome group was significantly lower than control group, but no difference 
  
was found in corneal endothelial density and anterior lens capsule thickness 
between PXS group and the control group. [17] 
 Ibrahim F Hepsen et al. studied the corneal curvature & the CCT in 
eyes with PXS (with & without glaucoma) and compared the values with 
normal eyes. It was concluded by them that the CC was significantly steeper in 
the eyes with PXS than the normal subjects. It was also inferred that there was 
no significant difference in the CCT between the eyes with PXS & the control 
group. However, a significant difference was observed in the CCT between the 
subjects with PXS with glaucoma and without glaucoma. The eyes with PXS 
without glaucoma had a significantly thinner CCT when compared with those 
eyes with PXS with glaucoma. [79] 
 Ozcura F et al. retrospectively analyzed the CCT and corneal curvature in 
48 eyes with PXS with and without glaucoma (19 with glaucoma, 29 without 
glaucoma) and compared them with 48 age-matched and sex-matched controls. It 
was observed that the average CCT was significantly thinner in all PXS eyes 
without glaucoma than in control eyes. However, there was no difference in the 
CCT between eyes with PXS and glaucoma and control eyes. No significant 
difference was found in the keratometry and axial length between the study and 
control groups. [80] 
  
 Spiridon Gorezis et al.  measured the central corneal thickness in 60 
eyes with primary open-angle glaucoma, 50 eyes with pseudoexfoliation 
glaucoma, 50 eyes with ocular hypertension using specular microscope and 
compared the values with the CCT of 60 control eyes without glaucoma or 
ocular hypertension. They found out that the central corneal thickness was 
significantly thinner in cases with pseudoexfoliation glaucoma and significantly 
thicker in cases with ocular hypertension when compared with the control 
group. [81] 
 Alpeza-Dunato Z et al. studied the CCT in 34 cases of 
pseudoexfoliation glaucoma, 31 cases of open angle glaucoma, 28 cases of 
angle closure glaucoma and 36 normal subjects without glaucoma with a non-
contact specular microscope and found that the patients with pseudoexfoliation 
glaucoma and open angle glaucoma had significantly thinner CCT compared 
with normal subjects in control group. [16] 
 Rana Sorkhabi et al on a study about exfoliation syndrome “Retinal 
Nerve Fiber Layer and Central Corneal Thickness in Patients with Exfoliation 
Syndrome”; found that retinal nerve fiber layer in exfoliation syndrome group 
was significantly thinner than control group, but no significant difference was 
observed in the central corneal thickness between the two groups. [82] 
  
 Puska et al. measured the CCT and IOP and assessed the corneal 
endothelium in 40 normotensive individuals with unilateral PXS and compared 
the values of the eyes with PXS with their fellow eyes without PXS and 
observed that the eyes with PXS showed no difference in the corneal 
endothelial morphology and density. However, the CCT was found to be 
significantly thicker in the eyes with PXS than the fellow eyes. The IOP was 
also significantly higher in the eyes with PXS than the fellow eyes after 
adjustment for CCT. [83] 
 S Popovic-Suic et al. measured the CCT in 24 cases of Pseudo 
exfoliation glaucoma, 20 cases of primary open angle glaucoma and 16 normal 
subjects without glaucoma using an ultrasonic pachymeter. One eye per 
individual was studied at a time. The mean CCT was almost similar in all the 
three groups and no statistically significant difference was made between them. 
They concluded that the CCT was not thinner in PEXG when compared with 
the other two groups and that thinner CCT was not found to be a risk factor for 
PEXG. [84] 
 Sobottka Ventura et al. measured the CCT with an optical low 
coherence reflectometer in 34 subjects with normal tension glaucoma, 20 with 
primary open angle glaucoma, 13 with pseudoexfoliation glaucoma, and 12 
with ocular hypertension and 21 control subjects. All the study subjects had 
  
bilateral involvement and one eye was selected randomly. It was found that the 
CCT was significantly higher in patients with ocular hypertension than in 
normal population or in individuals with normal tension glaucoma, open angle 
glaucoma or pseudoexfoliation glaucoma. No statistically significant difference 
was found to exist between the latter four groups. This study did not 
demonstrate a significant thinning of the central cornea in PEXG. [85] 
 Seydi Okumus et al.  retrospectively analyzed 159 cases with pseudo 
exfoliation (115 cases with cataract and 44 cases without cataracts) and 
compared the CCT in terms of average keratometric values and axial length 
with that of 60 normal subjects. In their study, a statistically significant 
difference was found to exist in the CCT between the eyes with 
pseudoexfoliation and those of the healthy subjects. The CCT was thinner when 
compared with the normal subjects.  However, no significant difference was 
noted in the keratometric values and axial length measurements between the 2 
groups. [86] 
 Civcic et al. measured the central corneal thickness in 26 eyes with 
normal tension glaucoma, 18 eyes with pseudoexfoliation glaucoma, 14 eyes 
with ocular hypertension and 88 eyes with primary open angle glaucoma using 
an ultrasonic pachymeter and compared them with 38 eyes without glaucoma 
which served as control group. They found that the CCT was significantly 
  
thinner in the eyes with normal tension glaucoma and significantly thicker in 
the eyes with ocular hypertension. However, there was no significant variation 
in the CCT in eyes with POAG and PEXG when compared with the control 
group. [87] 
 Georgios Kitsos et al. evaluated the CCT in 32 patients with bilateral 
PEXG, 55patients with bilateral POAG, 35 patients with PXS but without 
glaucoma, and 57 normal subjects without PXS using an ultrasound 
pachymetry. The CCT was found to be significantly thinner in the patients with 
PEXG. No significant variation was observed in the CCT between the patients 
with POAG, PXS and the healthy subjects. [88]  
 Emine Sen et al. studied the CCT in 120 subjects with POAG, 62 
subjects with PEXG, 51 subjects with NTG and 53 cases of ocular hypertension 
and 50 healthy subjects using an ultrasound bio pachymeter.  They found that 
the CCT was significantly thinner in subjects with NTG and significantly 
thicker in subjects with OHT. They also found out that no significant difference 
existed in the CCT of the subjects with POAG and PEXG when compared with 
the control group. They concluded that the measurement of CCT is mandatory 
for monitoring glaucoma cases or glaucoma suspects for proper diagnosis and 
follow-up of the disease. [89] 
  
 Stefaniotou et al. evaluated the CCT and corneal endothelium in 48 
patients with unilateral or bilateral pseudo exfoliation and compared the values 
against 48 normal subjects with no other ocular disease other than cataract. A 
significant decrease in the corneal endothelial cell density was observed along 
with a higher rate of polymegathism in the individuals with PXS when 
compared with the individuals without PXS. The CCT was found to be 
significantly thicker in the former group than the latter. However in patients 
with unilateral PXS, there was no significant difference in the CCT as well as 
the corneal endothelium between the eye with PXS and the fellow eye. [90] 
 Arnarsson et al., in their study entitled ‘Pseudo exfoliation in the 
Reykjavik eye study’ recruited 1045 subjects and evaluated the age and sex 
related prevalence of pseudo exfoliation in them. They also assessed other 
parameters like IOP, CCT, anterior chamber depth, lens thickness, optic disc 
diameter, the disc area and the cup disc ratio and compared them between the 
eyes with and without pseudo exfoliation.  The CCT was measured using 
Scheimflug photography in 952 eyes, out of which 65 subjects had PEXF and 
753 did not have PEXF. 134 subjects were excluded because the diagnosis of 
PEXF was not certain as very early exfoliative changes could not be ruled out. 
In this study, they did not find any significant difference in the CCT between 
the two groups after age and sex adjustments. [91] 
  
 Detorakis et al studied the central corneal mechanical sensitivity and the 
central corneal thickness in 40 patients with unilateral and bilateral pseudo 
exfoliation using the Cochet & Bonnet aesthesiometer & ultrasound pachymeter 
respectively and compared the same with 38 normal subjects without 
pseudoexfoliation. They inferred that the central corneal mechanical sensitivity 
was reduced in the eyes with PEXF and attributed it to decreased Schirmer’s 
test values & tear film BUT. However, they observed that there was no 
significant difference in the CCT between the two groups. [31] 
 Aghaian E et al., in a retrospective study, analyzed the CCT in different 
subgroups of the Asian population such as the Japanese, Hispanics, Chinese, 
Caucasians, Filipinos and African Americans and measured the outcomes in 
terms of its correlation with race, age, gender, the presence or absence of 
glaucoma, the type of glaucoma, history of intra ocular surgery etc. 801 patients 
were included in the study out of which 600 patients were with glaucoma of any 
type and 201 patients were without glaucoma. They found out that the CCT was 
significantly variable among the different populations. It was also made out that 
OHT patients had thicker corneas and elderly patients and those with POAG, 
PEXG, CACG and NTG had significantly thinner corneas when compared with 
the normal population. [46] 
  
 Yeshigeta Gelaw et al., in a multicentric cross sectional study, measured 
& analyzed the CCT & IOP in 199 patients with glaucoma. They found that a 
statistically significant linear relationship existed between CCT and IOP. 
Among the study population, patients with OHT and PEXG had thicker corneas 
and higher IOPs when compared with NTG and POAG patients. [92] 
 Yagci et al. measured the IOP using GAT and CCT using ultrasonic 
pachymeter in 26 cases of POAG, 25 cases of PEXG and 24 cases with OHT 
and compared the values with 50 normal subjects. Results analyzed showed a 
significantly higher CCT in the subjects with OHT. Though the CCT was 
relatively thinner in cases with PEXG than those with POAG and the normal 
subjects, the difference between the three groups (POAG, PEXG and normal 
subjects) were statistically insignificant. [93] 
 Bechmann et al. measured the central corneal thickness in 167 
individuals. Out of them 20 had primary open angle glaucoma , 42 had normal 
tension glaucoma, 22 had ocular hypertension, 10 had primary angle closure 
glaucoma, 24 had pseudoexfoliation glaucoma , 13 had Pigmentary glaucoma, 
and  remaining 36 were without glaucoma and were designated as controls. 
Their study revealed that the CCT was significantly thicker in patients with 
OHT than that of the control group. However, in the other groups such as NTG, 
PEXG and POAG, the CCT was significantly lesser than that of the control 
  
group. No statistically significant difference was found between the PIG group 
and the controls. [94] 
 The fact that CCT is thinner in PEXG has been demonstrated in most of 
the above studies. [16, 46, 81, 88, 94] However, the same has been contradicted by 
few other studies [80, 84, 85, 87, 89, 93] too as no significant difference in the CCT was 
made between PEXG subjects and the normal subjects. Another study [92] 
pointed out that the CCT was thicker in cases with PEXG. All these studies, 
except a few [91], have limitations such as a very small sample size. Moreover, 
instead of a single standard technique, different studies have employed different 
techniques such as ultrasound pachymeter, OCT, OLCR, Scheimflug 
photography, specular microscope, etc. 
 As most of these studies were cross sectional and retrospective, they were 
not able to document the CCT values of the subjects with PEXG prior to the 
development of glaucoma. There are certain prospective studies that have 
demonstrated the increased risk of developing glaucoma in PXS compared to 
those without PXS. [40] However, such studies too have not incorporated the 
CCT measurements in them.  
 However, few cross sectional studies have been done on the CCT in PXS 
(PEXF without glaucoma) and most of the studies [17, 78, 79, 80, 86] support the fact 
  
that the CCT is significantly thinner in eyes with PXS than in normal eyes 
without PXS, except few studies [31, 82, 91] that have demonstrated no significant 
difference in the CCT between the two groups.  
 The role of CCT in terms of  its correlation with IOP as an important tool 
in the diagnosis, classification, management and follow up of glaucoma has 
been well emphasized by various studies.[5,6]  Different studies have 
documented that CCT differs in different types of glaucoma and the IOP 
readings must be adjusted accordingly not only to ensure a correct diagnosis of 
glaucoma but also to determine the exact target pressure to be achieved and to 
ensure during follow- ups if the IOP has been really controlled to the desired 
level. 
 Various studies have proved that individuals with PXS are at a higher 
risk of developing glaucoma than those without PXS. [38,39,40]  PEXG has a 
worse prognosis than POAG as most of the patients present with significantly 
severe optic nerve damage at the time of diagnosis with a  worse visual field 
damage. The response to medical management is also poor and there is 
increased necessity for surgical intervention. [41] Most studies attribute the 
severity of glaucomatous damage in PEXG to the delay in diagnosis due to 
underestimation of the IOP by GAT because of thinner corneas and failure to 
  
achieve the actually desired target IOP. In most cases, the disease progresses 
with an apparently controlled IOP. As thinner CCT itself serves as an additional 
risk factor for the development of glaucoma in PXS, CCT measurement is 
mandatory in all PXS patients to facilitate early detection of glaucoma, 
determination of the exact target pressure to be achieved and monitoring the 
disease progression and the response to treatment.  
 
 
 
 
 
 
 
 
 
 
 
  
AIM: 
 
To compare the central corneal thickness in individuals with 
pseudo exfoliation syndrome and without pseudo exfoliation 
syndrome. 
 
OBJECTIVES: 
 
• To measure the central corneal thickness in individuals with 
pseudo exfoliation syndrome and compare it with that of 
individuals without pseudo exfoliation syndrome. 
• To compare the central corneal thickness in the eyes with pseudo 
exfoliation with their fellow eyes without pseudo exfoliation, in 
individuals with unilateral pseudo exfoliation syndrome. 
• To determine the influence of age and sex on central corneal 
thickness in both the study & control groups. 
• To evaluate the differences in intra ocular pressure between the 
study and control groups, before and after adjustment for CCT.  
• To emphasize the necessity for measuring the central corneal 
thickness in eyes with Pseudo exfoliation syndrome. 
  
  
MATERIALS & METHODS 
 This is a hospital based, cross sectional study undertaken at the 
Department of Ophthalmology, Coimbatore Medical College and Hospital, 
Coimbatore. 
 The study period was about 12 months extending from November 2012 
to October 2013. 
 Patients attending the Ophthalmology Out Patient Department & those 
admitted in the ward were selected on the basis of the following criteria:  
INCLUSION CRITERIA: 
• Adult patients of age 50 years & above with or without cataract. 
EXCLUSION CRITERIA: 
 Patients with the following conditions in any one or both the eyes were 
excluded from the study: 
• Any corneal pathology  
• Uveitis  
• Ocular trauma 
• History of glaucoma 
• IOP > 21 mm Hg 
  
• Field defects and fundus changes suggestive of glaucoma 
• History of contact lens wear 
• History of previous intra ocular surgeries. 
• Diabetes mellitus 
 All the patients aged 50 years and above were selected on the basis of the 
above criteria and written consent was obtained. A detailed history taking was 
done in order to rule out history of ocular trauma, intra ocular surgeries, contact 
lens wear, history of glaucoma, uveitis, corneal and other ocular diseases and 
history of medications for the same. History of diabetes mellitus and treatment 
for the same were ruled out. 
 A slit lamp examination was done in all patients with undilated pupil to 
rule out corneal pathologies like keratitis, corneal opacity, edema, scar, 
dystrophy, ectasia, and degeneration. Uveitis, conjunctival blebs, aphakia, 
pseudophakia were also ruled out. All were examined for the presence or 
absence of pseudo exfoliation. Pseudo exfoliation was diagnosed by the 
presence of white flakes or fibrillo granular material on the pupillary margin. A 
slit lamp examination was done again with a dilated pupil to detect presence of 
PEXF on anterior lens capsule. The presence or absence of cataract and if 
present the grading of cataract was noted. 
  
 Blood samples were taken to measure the blood glucose and urine 
analysis was done. Only those individuals with blood glucose values less than 
140 mg% and nil urine sugar were included in the study.   
 Visual acuity, visual field examination, gonioscopy and refraction were 
done for all patients. A detailed fundus examination was done to rule out 
glaucomatous changes. The IOP was measured using GAT. CCT was measured 
using ultrasonic pachymetry (PAC SCAN 300 P). The details of the patient, 
along with the IOP of both eyes were fed into the pachymeter. After instillation 
of 0.5% proparacaine, the patients were made to sit upright looking straight 
ahead. The tip of the hand held pachymeter probe was placed perpendicularly 
on the cornea and centered over the undilated pupil. An average of five 
consecutive readings were recorded. The predesigned software incorporated in 
the pachymeter auto adjusted the IOP according to the CCT and gave the true 
IOP along with the mean CCT value. 
 The patients with CCT adjusted IOP > 21 mm Hg, those with fields and 
fundus changes suggestive of glaucoma were excluded from the study.  
 The patients who fulfilled all the above criteria were designated as study 
subjects based on the presence of PEXF on the pupillary margin and/or the 
anterior lens capsule. Those without PEXF were designated as controls. A total 
  
of 100 subjects without PEXF and 50 subjects with PEXF were included in the 
study. Their IOP and CCT values were tabulated and analyzed for statistical 
significance. 
 The data analysis and interpretation was done using SPSS 16 version. 
The mean, standard deviation, standard error of mean, degree of freedom, 2-
tailed significance and 95 % confidence interval were calculated. Independent t 
test, one way analysis of variance (ANOVA) and Pearson’s correlation were 
used for analysis of the results. 
 
 
  
  
Figure11. Technique of Applanation tonometry 
 
Figure 12. Technique of Ultrasound Pachymetry 
 
 RESULTS AND OBSERVATION
 Among the 100 subjects of the control group, 40% were males and 60 % 
were females. In the 50 subjects of the PEXF group, 54% were males and
were females.  
Table 1. Gender distribution in Control and PEXF group
Gender Control Group
No. of 
patients 
Male 40 
Female 60 
Total 100 
 
The above data shows that 
were higher (54 %) than females (46%)
Chart 1. Gender distribution in Control and PEXF group
No.of Patients
Control Group
40
(40%)60
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 PEXF Group Total
% No. of patients % 
No. of 
patients
40 27 54 67 
60 23 46 83 
100 50 100 150 
within the PEXF group, the number of males 
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 Table 2. Overall gender
Gender Total 
patients
Male 67 
Female 83 
 
On estimating the overall gender distribution also, the distribution of 
PEXF was higher in males (40.3%) than in females (27.7%)
Chart 2. Overall gender
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 PEXF Group Control Group
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 Table 3. Age distribution in Control and PEXF group
Age 
Control Group
No. of 
patients 
50-59  30 
60-69 48 
70-79 20 
80 
&above 2 
Total 100 
 
 The above table shows that most of the patients in the control group 
belonged to the age group of 60
the PEXF group were in the age group of 70
years. Thus this table shows that t
were maximum in the age group of 70
Chart 3. Age distribution in Control and PEXF group
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      Table 4. Overall age
Age 
(Years) 
Total 
50-59 40 
60-69 66 
70-79 39 
80 & above 5 
Total 150 
 
The above table shows that distribution of PEXF is 
aged   > 80 years(60%), followed by 48.7 % in those betwe
and 27.3 % in those aged 60
Chart 4. Overall age
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 Table 5. Distribution of Laterality in PEXF group
 
Bilateral 
PEXF 
No.of cases 30 
Percentage 60% 
 
 The above table shows that in the PEXF group, 60% had bilateral PEXF 
and 40 % had unilateral PEXF (18 % in RE alone and 22% in LE alone)
Chart 5. Distribution of laterality in PEXF group
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Table 6. Overall age-wise distribution of CCT 
Age group 
(years) Total No. of Patients 
Mean CCT 
(in mm) 
50-60 40 0.513 
60-70 66 0.513 
70-80 39 0.512 
>80 5 0.476 
Total 150 0.511 
 
 The above table shows that the mean CCT is almost same in all age 
groups except those aged 80 years and above, in whom there is marked 
decrease in CCT compared to the other three groups. However there was no 
significant statistical correlation between age and CCT (p value=0.352)    
     ANALYSIS OF VARIANCE 
CCT Sum of Squares df 
Mean 
Square F Sig. 
Between groups 0.004 3 0.001 1.099 0.352 
Within groups 0.170 144 0.001   
Total 0.174 147    
 
 
 Chart 6. Overall age
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 Table 7. Mean CCT in Control group 
 
 The above table shows that the mean CCT in the control group without 
PEXF is 0.517 + 0.07 mm in BE. This also shows that there is no difference in 
the CCT value between both eyes. 
Chart 7. Mean CCT in Control group
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 Table 8. Gender
                             
 Gender No. of patients
RE 
Male 
Female 
LE 
Male 
Female 
 
 The above table shows that the mean CCT in males is 0.520 
and 0.521 + 0.07  mm in the RE and LE respectively. In females, it is 0.515 
0.07 mm in the RE and 0.514 
CCT between both eyes in both genders.
Chart 8. Gender-wise distribution of CCT in control group (in mm)
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Independent samples test 
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for equality of 
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 The mean CCT is found to be slightly higher in males than that of 
females in both eyes. However, this difference is statistically insignificant        
(P value RE=0.476 LE=0.316). 
 
 
 
 
 
 
 
 
 
 
 Table 9. 
No. of 
patients  
50 
RE 
LE 
  
 The above table shows that the mean CCT in the PEXF group is 0.501 
0.07 mm in RE and 0.500 
difference in the CCT value between both eyes. 
Chart 9. Mean CCT in PEXF group
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Table 10. Gender-wise distribution of CCT in PEXF group 
 Gender No. of patients 
Mean CCT 
(in mm) 
Std 
deviation 
Std error 
mean 
RE 
Male 27 0.504 0.03551 0.00683 
Female 23 0.497 0.03489 0.00728 
LE 
Male 27 0.504 0.03170 0.00610 
Female 23 0.495 0.03327 0.00694 
 
 The above table shows that the mean CCT in males is 0.504 + 0.07 mm 
RE and 0.504 + 0.06 mm in LE. In females, it is 0.497 + 0.07 mm in the RE and 
0.495 + 0.07 mm. There is no significant difference in CCT between both eyes 
in both genders.  
Independent samples test 
Mean CCT 
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of variances 
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  The mean CCT is found to be slightly 
females in both eyes. However, this difference is statistically insignificant
(P value RE=0.492 LE=0.339)
Chart 10. Gender wise distribution of 
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 Table 11 Gender
Gender No of patients
Male 67 
Female 83 
 
Chart 11. Gender-
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 The above table and column chart show that the CCT is slightly thinner 
in females when compared with males. However, the difference was 
statistically insignificant (P value= 0.436). 
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 Table 12.Comparison of CCT between both eyes in B/L PEXF group
No of 
patients  
30 
RE 
LE 
 
 No variations were observed in the CCT of both the eyes of bilateral 
PEXF group.  
Chart 12. Comparison of CCT between both eyes in B/L PEXF group
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 Table 13. Comparison of CCT between both eyes in U/L PEXF group 
No of 
patients  
Mean CCT 
(in mm) 
Std. 
Deviation 
Std. Error 
Mean 
20 
Eye with PEXF 0.494 .028644 .006405 
Eye without PEXF 0.499 .033630 .007520 
 
 Among the 20 cases with unilateral PEXF, the eye with PEXF had a thinner 
CCT (0.494 + 0.06 mm) when compared with the fellow eye without PEXF  
(0.499 + 0.07 mm). However, this difference was statistically insignificant              
(P value =0.644) 
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 Chart 13. Comparison of CCT 
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Table 14. Overall comparison of CCT between Control & PEXF group 
 
  
 The above table shows that the CCT is significantly thinner in both the 
eyes of PEXF group than both the eyes in the control group without PEXF       
(P value RE= 0.008 LE = 0.003) 
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GROUP No. of patients 
MEAN CCT(in mm) 
RE LE 
Without PEXF 100 0.517 0.517 
With PEXF 50 0.501 0.499 
 Chart 14. Mean CCT 
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Table 15.  Overall comparison of CCT in eyes with and without PEXF 
Group No. of patients 
Mean CCT 
(in mm) 
Std. 
Deviation 
Std. Error 
Mean 
Eyes with 
PEXF 80 0.501 .033767 .003775 
Eyes without 
PEXF 220 0.515 .034318 .002314 
 
Independent samples test 
CCT 
Levene’s test 
for equality of 
variances 
t-test for equality of means 
F Sig. T Df 
Si
g 
(2 
ta
ile
d)
 
Mean 
diff 
Std 
error of 
mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Eq.variance 
assumed 
 
 
Eq.variances 
not assumed 
1.880 
 
 
 
.171 
 
 
 
-3.252 
 
 
-3.277 
298 
 
 
142.248 
.001 
 
 
.001 
-.01451 
 
 
-.01451 
.004462 
 
 
.004428 
-.02329 
 
 
-.02326 
-.00573 
 
 
-.00576 
  
 Comparison of 80 eyes with PEXF in the PEXF group with the 220 eyes 
without PEXF (200 eyes in the control group and 20 eyes in the unilateral 
PEXF group) also showed a significant thinning in the eyes with PEXF                
(P value=0.001) 
 
 Chart 15. Overall comparison of CCT in eyes with and without PEXF
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Table 16 Comparison of CCT between the eyes without PEXF in 
unilateral PEXF group and the Control group. 
Group No. of patients 
Mean CCT 
(in mm) 
Std. 
Deviation 
Std. Error 
Mean 
Eyes without 
PEXF in U/L 
PEXF group 
20 0.499 .033630 .007520 
Eyes without 
PEXF in 
Control group 
200 0.517 .034010 .002405 
 
The above table shows that the mean CCT is significantly thinner even in 
the eyes without PEXF in the unilateral PEXF group when compared with the 
normal group. (P value= 0.021) 
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 Chart 16. Comparison of CCT between the eyes without PEXF in U/L 
PEXF group and the 
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 Table 17. Comparison of IOP between Control and PEXF group   before 
 
RE 
LE 
         
 The above table shows that the IOP is similar between the 2 groups in
eye. In right eye, the IOP is slightly higher in the control group
group. However, the difference is statistically insignificant.
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 Table 18. Comparison of IOP before & after CCT correction in control 
 
RE 
LE 
 
 The above table shows 
mm Hg in RE and 2 mm Hg in LE after CCT correction in the control group. 
This increase in IOP was statistically significant. (P value=0.000)
Chart 18. IOP before & after CCT correction in control group.
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Paired Samples Correlations 
IOP before & 
after CCT 
Correction in 
Control group 
N Correlation Sig. 
100 0.640 0.000  
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 Table 19. Comparison of IOP before & after CCT correction in PEXF 
 
RE 
LE 
 
 The above table shows that there is an increase in the IOP of  about  
3.1mm Hg in RE and 3.2 mm Hg in LE after CCT correction in both eyes of the 
PEXF group. The increase in IOP was statistically significant. (P 
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Table 20. Comparison of IOP after CCT correction between the control 
group and PEXFgroup. 
 
MeanIOP after CCT correction(mm Hg) 
RE LE 
Control Group 15.4 15.2 
PEXF Group 16.2 16.4 
 
 The above table shows that the IOP after CCT correction is higher in the 
PEXF group than the control group. The difference was statistically significant 
between the two groups.(P value=0.049) 
Chart 20. Comparison of IOP between Control & PEXF group after CCT 
Correction 
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DISCUSSION 
 
 Pseudo exfoliation is the most common cause of secondary open angle 
glaucoma. The Blue Mountains eye study showed that the incidence of 
glaucoma in eyes with PEXF is 9 times higher (14.2%) than the eyes without 
PEXF (1.7%). [95]The eyes with PEXF have a higher risk, which is independent 
of other risk factors including IOP. [95]They are associated with a thinner          
CCT,[17] which leads to an underestimation of IOP and thereby a delayed 
diagnosis. Thinner CCT itself serves as another independent risk factor for 
development of glaucoma.[15] All these factors coupled together place the 
individuals with PEXF at a very high risk of advanced glaucomatous damage 
than primary open angle glaucoma.  
 As this study is hospital based, exact prevalence of pseudo exfoliation 
could not be estimated. However, the distribution of PEXF was found to be 
more among males both within the PEXF group and the overall population 
included in the study. This is in accordance with study by Krishnadas et al. [19] 
(The Aravind Comprehensive eye survey). 
 The distributionof PEXF was found to be apparently higher in the age 
group of 70-79 years. However, after  matching for age between the study and 
control groups, the distribution of PEXF was greatest in those aged > 80 years 
  
(60%) and least in those aged <60 years(25%). This is in accordance with 
various studies that have shown that prevalence of pseudo exfoliation increases 
with increasing age.  Similar results were observed in the studies by Krishnadas 
et al.[19] ( The Aravind Comprehensive eye survey) and Mitchell et al. [95]           
(The Blue Mountains eye study). 
 The CCT was evaluated using an ultrasonic pachymeter. A minimum of 3 
measurements are required for an accurate measurement. [96]The reliability of 
measurements is fairly good in this study as five measurements were taken for 
each eye.   
 In the control group without PEXF, the mean CCT was 0.517 mm. There 
was no significant difference between both the eyes. Within the group, the CCT 
was slightly thinner in females when compared with males. This was similar to 
the study by Shimmyo et al. and various other studies. [8, 97] However, this 
difference was statistically insignificant. (P value = 0.388) 
 The mean CCT in PEXF group was 0.501 mm in RE and 0.500 mm in 
LE. There was no significant difference in CCT between both the eyes. In this 
group also, the CCT was slightly thinner in females than males. This difference 
was also statistically insignificant (P value RE= 0.492 LE= 0.339) 
  
 The analysis of CCT in both genders in the overall population included in 
the study also showed that the CCT was thinner in females than males. 
However, this too proved insignificant following statistical analysis                  
(P value=0.436) 
 Different studies have shown that there is no difference in CCT between 
both genders [49] and few studies have shown that CCT is higher in females.[50] 
 Most of the studies have reported that CCT decreases with age. [8, 9, 10, 47, 
48] But, in this study, a significant relationship was not established between age 
and CCT. The mean CCT was almost similar in all the groups. There was a 
decrease in CCT in those aged more than 80 years when compared with those 
aged less than 80 years. However, 60% of them had PEXF and hence the 
thinning was whether due to age or the presence of PEXF could not be 
ascertained. The difference was statistically insignificant too.(P value=0.352) 
Certain  other studies have also shown that there is no significant relation 
between CCT and age.[97,98] 
 The comparison of CCT between the control group and the PEXF group 
showed that the CCT was thinner in the PEXF group than the control group 
without PEXF. This difference proved to be statistically significant too.                
(P value RE= 0.008 LE =0.003).   
  
To support this, an overall comparison of the CCT was made between the 
80 eyes with PEXF and the 220 eyes without PEXF (200 eyes of the control 
group and the 20 fellow eyes without PEXF in the unilateral group). This also 
showed a significant thinning of the central cornea in those 80 eyes with PEXF 
than the 220 eyes without PEXF. (P value=0.001) 
This shows that the presence of pseudo exfoliation is strongly associated 
with a significant thinning of the cornea. This is attributed to the apoptosis of 
the keratocytes of the anterior corneal stroma. [30]Similar results were 
established by the studies by Hepsen et al , Mohammed Ali Zare et al.and 
various others.[17,79 ] 
A still stronger evidence of the association of PEXF with a thinner CCT 
can be established if the CCT is compared between the eye with PEXF and the 
fellow eye without PEXF in the same individual. This may eliminate the age 
and gender related bias. 
So far only very few studies have been reported analyzing the difference 
in CCT between both eyes with unilateral PEXF. One such study [83] showed 
that the CCT was thicker in the eye with PEXF than the fellow eye without 
PEXF. This was contradictory to all other studies which showed that PEXF is 
associated with thinner CCT. The limitation of this study was that it did not 
compare the CCT of either eyes with the normal population. Had there been a 
  
comparison with normal population, the influence of PEXF on CCT could have 
been established still clearly. 
In this study, the difference in CCT between the eye with PEXF and its 
fellow eye without PEXF was analyzed in the 20 patients with unilateral PEXF. 
The eyes with PEXF had a slightly thinner CCT (0.494 mm) than the eyes 
without PEXF (0.499mm). However, the difference was statistically 
insignificant (p value= 0.644). 
Based on this alone, it cannot be concluded that the association of PEXF 
with thinner CCT in this study is only a coincidence. The fellow eyes of eyes 
with PEXF, though did not show evidence of PEXF by slit lamp examination, 
might have had occult deposition of PEXF material in the ocular structures 
which are too difficult to be detected by clinical examination.  
This is supported by the discovery of the fact by Zheng et al. [30] who 
studied the ultra structural changes in eyes with unilateral PEXF by in vivo 
confocal microscopic examination and compared them with the fellow eyes 
without PEXF and also the control population without PEXF.  They observed 
that the corneal endothelial cell density was significantly reduced in both the 
eyes with PEXF and their fellow eye without any clinical signs of PEXF. They 
also reported that there was evidence of deposition of  hypereflective material 
suggestive of PEXF on the corneal endothelium, not only in the eyes with 
  
PEXF but also in 51.9% of the fellow eyes without PEXF. The subbasal nerve 
plexus also showed changes in the fellow eyes similar to the eyes with PEXF. 
Therefore, they suggested that the fellow eyes could have been in a preclinical 
stage of PEXF. [30] 
Few other studies have also shown that when one eye was affected by 
PEXF, the unaffected fellow eye had abnormal aqueous humour dynamics. 
Most of the unaffected fellow eyes demonstrated pigment related signs of 
PEXF. Almost all of the uninvolved fellow eyes demonstrated pseudo 
exfoliation material in conjunctival biopsy. [29, 99] Hence, they suggested that the 
term unilateral PEXF may be misleading. Most of the individuals with pseudo 
exfoliation have bilateral but asymmetric involvement which cannot be detected 
by clinical examination. 
Based on the above studies, it can be explained that the 20 subjects with 
unilateral pseudo exfoliation in this study might have had asymmetric 
involvement with the fellow eyes without PEXF being at a preclinical stage and 
this could be the reason for the absence of any significant difference in the CCT 
between the two eyes.  
A comparison of CCT was made between the 20 eyes without PEXF in 
the unilateral PEXF group and the 200 eyes without PEXF in control group. 
  
The 20 fellow eyes of eyes with unilateral pseudo exfoliation though did not 
have any evidence of PEXF on slit lamp examination, had a significantly 
thinner CCT when compared with the 200 eyes of the control group. This 
difference, proved to be statistically significant too (P value=0.021). This too 
supports the fact that those 20 eyes might have been at a pre clinical stage of 
PEXF. However, more sophisticated techniques like in vivo con focal 
microscopic examination are required to support this fact. 
The mean IOP before adjusting for CCT value was almost similar in both 
eyes of the control group. Following adjustment of the IOP values for the CCT 
values, there was an increase in the IOP of about 1.95 mm Hg in both                    
the eyes. The increase in IOP was found to be statistically significant too.        
(P value= 0.000) 
In the PEXF group, the average IOP before adjustment for CCT was 
13.1mm Hg and 13.2 mm Hg in the right and left eyes respectively. The 
difference in IOP between both eyes was very minimal. Following adjustment 
of IOP for CCT, there was an increase of about 3.1 mm Hg in the IOP of both 
the eyes.  The increase in IOP was statistically significant too. (P value=0.000) 
Both the control and the PEXF groups had an almost similar IOP before 
CCT correction. There was a significant increase in the IOP following 
  
adjustment for CCT in both the groups. This shows that the IOP has been 
underestimated by GAT in both the control group and the PEXF group. The 
underestimation in the IOP in the PEXF group can be explained by the presence 
of pseudo exfoliation and the associated significant corneal thinning which 
causes an underestimation. 
However, there was an underestimation of  IOP in the control group too 
which suggests that the CCT is thinner than the average in the control group 
too. The reason for thinner corneas in the study group, without any obvious 
local or systemic causes, is unclear. A possible explanation for this could be 
offered by the fact that the CCT differs in different population. Various studies 
have proven the same. [7, 43] Moreover, the definition of mean CCT has also 
been controversial. There is a wide variation within a given population. 
[44]While few studies show that the average CCT in Indian population is 0.520 
mm, 
[45] there are few other studies which show that it is about 0.545 mm.[46] A 
prefixed mean CCT, therefore, cannot be applied for every population. 
In this study, the pachymetry device used has been calibrated in such a 
way that the mean CCT is 0.545 mm. Any value below this, will underestimate 
the IOP and any value above this overestimates the IOP. The control group had 
a mean CCT of only 0.517 mm. This explains why there is an underestimation 
of IOP in them. 
  
However, this mean CCT observed in the study population may not be 
applicable to the entire community. An exact estimation of the mean CCT can 
be estimated only through population based study. This study being hospital 
based cannot give an exact estimation of the average CCT. 
The significant increase in IOP following adjustment of CCT even in the 
control groups observed in the study emphasizes the measurement of CCT in all 
the patients during glaucoma patients and adjusting the IOP measurements 
accordingly for an accurate measurement of the true IOP. 
Although the mean CCT was slightly thinner in the control group, it was 
considered as the baseline CCT for the entire study population and the CCT in 
PEXF group was compared with it. The PEXF group demonstrated a still more 
thinning than the control group which was statistically significant too. This 
shows that there is a strong association of PEXF with thinner CCT. 
Initially, the IOP before adjustment for CCT was similar in both the 
study and control groups and both the groups showed a significant increase in 
the IOP following adjustment for CCT. However this increase in IOP was 
dissimilar (1.9 mm Hg in the control group versus 3.1 mm Hg in the PEXF 
group). The CCT adjusted IOP was higher in the PEXF group than the control 
group and the difference was statistically significant too. (P value=0.049) The 
higher IOP in the PEXF group after CCT adjustment is explained by the fact 
  
that the CCT is significantly thinner in them and therefore they had a more 
pronounced underestimation of the IOP than the control group. 
Most of the studies have shown that the IOP is higher in eyes with PEXF 
than the eyes without PEXF. [100]  A similar result was also obtained in this 
study. However, the difference between the 2 groups, although statistically 
significant, was not that higher as observed in other studies. The reason for this 
could be attributed to the measurement of IOP only once during the study. The 
diurnal variation of IOP was not taken into account. Studies by Altintas et 
al.[101] have shown that the diurnal variation in IOP is more pronounced in 
individuals with PEXF than those without PEXF. Measurement of diurnal 
variation of the IOP could have demonstrated a still higher IOP in the PEXF 
group than the control group. 
This study has demonstrated that the CCT is thinner than average in both 
the study group and the control group and therefore emphasizes the 
measurement of CCT in all individuals for an accurate measurement of IOP.    
The PEXF group exhibited a still more significant thinning of the central cornea 
and a significantly higher risk of underestimation of IOP compared with the 
control group. The individuals with pseudo exfoliation are at greater risk of 
developing glaucoma than those without PEXF. A thinner CCT itself may act as 
an additional risk factor for development of glaucoma and along with this, there 
  
is an underestimation of IOP resulting in a delay in diagnosis. All these factors 
lead to advanced disease at the time of presentation. 
Measurement of CCT, therefore, is necessary in all cases of pseudo 
exfoliation for prediction of the risk of development and progression of 
glaucoma, for early diagnosis and to ensure adequacy of treatment. 
  
  
  
CONCLUSION 
 The distribution of pseudo exfoliation was more common in males than 
females. The distribution of pseudo exfoliation was higher in older individuals 
than younger individuals. There was no significant relation between age and 
central corneal thickness. The mean CCT was slightly lower in females when 
compared with males in both individuals with pseudo exfoliation and without 
pseudo exfoliation. However, this difference proved to be statistically 
insignificant.  
 The CCT was significantly thinner in the eyes with pseudo exfoliation 
than the eyes without pseudo exfoliation. In individuals with bilateral pseudo 
exfoliation, there was no significant difference between both eyes. However, in 
the individuals with unilateral pseudo exfoliation, a slightly lower CCT was 
observed in the eye with pseudo exfoliation compared to the fellow eye without 
pseudo exfoliation. This difference, however, was statistically insignificant. 
 Moreover, both the eyes in individuals with unilateral pseudo exfoliation, 
irrespective of the presence or absence of pseudo exfoliation exhibited a 
statistically significant thinning when compared with the individuals without 
pseudo exfoliation. This suggests that the fellow eyes of eyes with PEXF might 
have been at a pre-clinical stage which can be demonstrated only by 
  
ultrastructural studies like electron microscopy and in vivo confocal 
microscopy. 
 There was an underestimation of IOP by GAT in both the groups. 
However, the underestimation of IOP was more pronounced in the individuals 
with pseudo exfoliation.  
 Pseudo exfoliation itself is a major risk factor for the development of 
glaucoma. Being associated with thinner corneas which serve as another 
independent risk factor for the development and progression of glaucoma, the 
individuals with pseudo exfoliation are at still greater risk of developing 
glaucoma. The underestimation of the intra ocular pressure in these individuals 
further worsens the prognosis due to a delay in diagnosis and inadequate IOP 
control.  
 The measurement of CCT is therefore mandatory in the individuals with 
pseudo exfoliation syndrome to predict the risk of development of glaucoma, to 
facilitate early diagnosis and ensure adequacy of treatment.  
  
  
SUMMARY 
 This study entitled ‘Central corneal thickness in individuals with and 
without pseudo exfoliation syndrome’ is a hospital based comparative study. 
 Individuals with pseudo exfoliation syndrome are at higher risk for 
developing glaucoma than those without pseudo exfoliation syndrome. When 
they are associated with thinner central corneal thickness, which is an 
independent risk factor for glaucoma development and progression, the risk of 
glaucomatous optic nerve damage increases many fold. They are likely to be 
diagnosed late because of an underestimation of IOP by applanation tonometry. 
 The aim of the study was to compare the CCT in individuals with pseudo 
exfoliation syndrome and those without pseudo exfoliation syndrome. 
 A total of 100 normal subjects without PXS and 50 subjects with PXS 
without any corneal pathology or glaucoma were included in the study. Their 
CCT and IOP were measured and compared. The influence of CCT on IOP 
measurements were analyzed in both the groups. 
 It was concluded that the CCT is thinner in individuals with PXS than 
those without PXS. In the patients with unilateral pseudo exfoliation syndrome, 
there was no significant difference between the eye with & without PXS. It was 
  
presumed that the fellow eye without PEXF in individuals with unilateral PXS 
might have been at a preclinical stage. The IOP was underestimated in both the 
groups by applanation tonometry. However, the underestimation was more 
pronounced in individuals with PXS because of thinner CCT.  
 Thus, this study emphasizes the measurement of CCT in PXS to predict 
the risk of developing glaucoma, to facilitate early diagnosis and ensure 
appropriate management by an accurate measurement of IOP. 
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PROFORMA 
 
Name: 
Age: 
Sex:                     Male/ Female. 
OP/IP No.: 
Occupation: 
Complaints: 
 
History: 
 
• History of ocular trauma:  Yes/ No 
• History of intra ocular surgeries: Yes/No 
• History of contact lens wear: Yes/No  
• History of glaucoma: Yes/No  
• History of uveitis: Yes/No 
• History of corneal disease: Yes/No 
• History of any other ocular diseases: Yes/No 
• History of medications for any ocular disease: Yes/ No  
• History of diabetes mellitus: Yes/No 
 
 
 
 
 
Ocular examination:  
Visual acuity 
OD   OS 
  
Anterior segment examination with a slit lamp      
 OD OS 
Lids    
Conjunctiva   
Cornea   
Anterior chamber   
Iris   
Pupil    
Presence of pseudo exfoliation   
Lens   
Extra ocular movements                       
Visual field examination                       
IOP (by GAT)                                        
CCT (by ultrasound pachymetry)       
IOP after adjustment for CCT   
Gonioscopy                                             
Slit lamp examination with a dilated pupil 
 OD OS 
Pseudo exfoliation on anterior lens 
capsule                  
Refraction   
Fundus examination   
DIAGNOSIS: 
Random blood sugar: 
BP: 
Urine sugar: 
 
 
 
CONSENT FORM 
 I hereby consent to participate in this study entitled ‘CENTRAL 
CORNEAL THICKNESS IN INDIVIDUALS WITH AND WITHOUT 
PSEUDOEXFOLIATION SYNDROME’. I have been explained in detail about 
the nature of the study by the doctor knowing which I                    
Mr. / Ms. ………………………………….. wholeheartedly volunteer to 
participate in this study. 
 
Signature of the Volunteer  
 
Signature of the witness 
Date: 
KEY TO MASTER CHART 
 M-Male 
 F- Female 
 RE Right Eye 
 LE Left Eye 
 SIMC- Senile Immature Cataract 
 SMC- Senile Mature Cataract 
 V/A- Visual acuity 
 HM- Hand Movements 
 CFCF- Counting Fingers Close to Face. 
 PEXF- Pseudo exfoliation 
 + Presence of PEXF 
 - Absence of PEXF 
 IOP- Intra ocular Pressure 
 CCT-Central Corneal Thickness 
 BP- Blood Pressure 
 RBS- Random Blood Sugar 
 U/S- Urine sugar 
 
  
RE LE RE LE RE LE RE LE RE LE RE LE
1 17538 63 M SIMC SIMC _ _ 6/18 6/12 19 19 0.565 0.573 17.6 17 102 120/80 _
2 10766 60 M SIMC SIMC _ _ 5/60 6/60 16 16 0.534 0.534 16.7 16.7 98 110/80 _
3 12346 67 M SIMC SIMC _ _ 5/60 6/18 18 18 0.578 0.582 15.7 15.4 84 120/90 _
4 4588 70 F SIMC SIMC _ _ 6/36 6/36 10 10 0.534 0.534 10.7 10.7 78 110/70 _
5 67108 55 F SIMC SIMC _ _ 2/60 6/36 8 8 0.492 0.49 11.7 11.9 96 110/70 _
6 67049 85 M SIMC SIMC _ _ 6/24 2/60 14 14 0.453 0.464 20.5 19.7 121 120/70 _
7 67119 50 M SIMC SIMC _ _ 6/18 1/60 12 12 0.551 0.55 11.6 11.6 129 110/70 _
8 67106 50 M SIMC SIMC _ _ 6/36 2/60 16 16 0.535 0.535 16.7 16.7 118 120/80 _
9 67260 74 M SIMC SIMC _ _ 6/18 6/24 14 14 0.531 0.525 15 15.4 85 120/80 _
10 67519 50 F SIMC SIMC _ _ 6/18 6/18 14 14 0.506 0.51 16.7 16.4 124 150/80 _
11 67579 60 M SIMC SIMC _ _ 6/36 6/36 15 16 0.501 0.501 18.1 19.1 97 160/100 _
12 67491 53 M SIMC SIMC _ _ 3/60 3/60 16 19 0.541 0.56 16.3 18 113 160/100 _
13 67578 55 M SIMC SIMC _ _ 4/60 4/60 10 11 0.475 0.475 14.9 15.9 92 140/80 _
14 67520 65 F SIMC SMC _ _ 6/18 HM 12 12 0.502 0.502 15 15 139 130/80 _
15 67580 61 M SIMC SIMC _ _ 4/60 5/60 12 12 0.566 0.561 10.6 10.9 139 120/80 _
16 67810 65 M SIMC SIMC _ _ 4/60 6/60 14 12 0.487 0.489 18.1 15.9 76 170/100 _
17 67811 74 F SIMC SIMC _ _ 4/60 3/60 10 10 0.49 0.502 13.9 13 83 130/60 _
18 67809 63 M SIMC SIMC _ _ 1/60 4/60 13 13 0.508 0.512 15.6 15.3 79 110/70 _
19 68208 60 F SIMC SIMC _ _ 4/60 1/60 16 16 0.502 0.486 19 20.2 92 110/70 _
20 68027 50 F SIMC SIMC _ _ 6/60 6/60 17 17 0.564 0.549 15.7 16.7 85 130/90 _
21 68486 65 M SIMC SIMC _ _ 6/24 2/60 10 10 0.545 0.534 10 10.7 112 170/110 _
22 74835 65 F SIMC SIMC _ _ 6/24 6/36 14 12 0.533 0.53 14.8 13 83 120/80 _
23 17564 65 M SIMC SIMC _ _ 6/60 6/24 9 9 0.469 0.474 14.3 13.9 83 120/80 _
24 68343 55 F SMC SIMC _ _ HM 1/60 14 12 0.569 0.565 12.3 10.6 85 120/80 _
25 17630 68 F SMC SMC _ _ 1/60 HM 14 14 0.561 0.552 12.9 13.5 120 140/80 _
26 68488 60 F SIMC SIMC _ _ 6/24 1/60 14 10 0.534 0.534 14.7 10.7 136 200/100 _
27 17334 50 M SIMC SIMC _ _ 2/60 3/60 13 12 0.436 0.453 20.6 18.5 117 150/100 _
28 68029 70 F SIMC SIMC _ _ 6/18 6/24 14 16 0.562 0.551 12.8 15.6 119 150/90 _
29 17413 72 F SIMC SIMC _ _ 3/60 6/36 12 14 0.497 0.494 15.4 17.6 109 140/90 _
30 68030 90 M SIMC SIMC _ _ 6/60 5/60 14 12 0.469 0.469 19.3 17.3 93 170/90 _
31 68485 60 F SIMC SIMC _ _ 2/60 6/36 18 17 0.502 0.504 21 19.8 138 150/80 _
32 17352 73 M SIMC SIMC _ _ 6/36 6/24 10 10 0.528 0.524 11.2 11.5 128 120/80 _
33 17563 60 M SIMC SMC _ _ 6/36 HM 15 14 0.556 0.551 14.3 13.6 89 110/70 _
34 13084 50 M SIMC SIMC _ _ 6/60 6/60 12 12 0.508 0.501 14.6 15.1 92 110/70 _
35 17706 75 F SIMC SIMC _ _ 5/60 6/60 16 16 0.549 0.552 15.7 15.5 122 130/80 _
36 68772 65 F SIMC SIMC _ _ 6/24 6/24 18 15 0.551 0.552 17.6 14.5 138 120/80 _
37 68778 50 F SIMC SIMC _ _ 4/60 6/36 14 13 0.502 0.502 17 16 101 100/70 _
38 68770 65 F SIMC SIMC _ _ 6/24 6/36 14 16 0.551 0.551 13.6 15.6 89 140/100 _
39 68769 65 F SIMC SIMC _ _ 6/24 6/36 13 12 0.521 0.519 14.7 13.8 123 130/90 _
40 68768 62 F SIMC SIMC _ _ 6/36 6/60 14 13 0.529 0.519 15.1 14.8 92 140/100 _
41 68775 62 F SIMC SIMC _ _ 6/36 3/60 10 11 0.485 0.482 14.2 15.4 139 150/100 _
42 68780 65 F SIMC SIMC _ _ 6/24 6/36 14 10 0.472 0.479 19.1 14.6 127 130/80 _
U/S
DIAGNOSIS
SEXAGESL NO
PEXF VISUAL ACUITY IOP MEAN CCT
IOP AFTER CCT 
CORRECTION
RBS BPOP/IP No.
43 68774 62 F SMC SIMC _ _ CFCF 3/60 14 14 0.543 0.545 14.1 14 130 130/90 _
44 68771 65 F SIMC SIMC _ _ 2/60 4/60 12 10 0.534 0.534 12.7 10.7 111 140/100 _
45 68766 58 F SIMC SIMC _ _ 6/36 1/60 10 10 0.471 0.47 15.2 15.2 79 110/70 _
46 68924 78 M SIMC SIMC _ _ 6/36 4/60 16 16 0.516 0.489 18 19.9 90 130/80 _
47 68904 53 M SIMC SIMC _ _ 6/24 6/18 15 16 0.537 0.512 15.5 18.3 134 130/80 _
48 68959 78 M SIMC SIMC _ _ 5/60 1/60 10 8 0.508 0.502 12.6 11 96 100/70 _
49 69028 70 F SMC SIMC _ _ HM 1/60 14 12 0.513 0.502 16.2 15 110 110/70 _
50 69279 60 F SIMC SIMC _ _ 1/60 1/60 16 14 0.554 0.555 15.4 13.3 125 90/60 _
51 69280 67 M SIMC SMC _ _ 6/18 HM 10 8 0.502 0.503 13 10.9 123 160/90 _
52 69281 66 F SIMC SIMC _ _ 6/60 5/60 14 14 0.485 0.484 18.2 18.2 95 130/80 _
53 69232 50 F SIMC SIMC _ _ 1/60 2/60 10 10 0.55 0.548 9.6 9.8 92 100/80 _
54 17697 50 F SIMC SMC _ _ 6/60 HM 8 8 0.5 0.502 11.1 11 123 100/70 _
55 70081 75 F SIMC SIMC _ _ 6/60 2/60 18 18 0.566 0.569 16.6 16.3 85 160/90 _
56 17590 55 F SIMC SIMC _ _ 1/60 2/60 10 11 0.487 0.485 14.1 15.2 132 140/80 _
57 70080 60 M SIMC SIMC _ _ 6/36 6/60 12 10 0.469 0.483 17.3 14.3 120 130/80 _
58 70042 60 F SIMC SIMC _ _ 6/36 2/60 12 12 0.567 0.58 10.4 9.6 136 140/70 _
59 70121 67 M SIMC SIMC _ _ 2/60 1/60 20 23 0.549 0.585 19.7 20.2 130 120/70 _
60 70064 57 M SIMC SIMC _ _ 6/36 6/36 13 10 0.506 0.502 15.7 13 60 110/80 _
61 70353 53 M SIMC SIMC _ _ 6/18 1/60 13 13 0.485 0.491 17.2 16.8 80 140/80 _
62 70355 65 F SIMC SIMC _ _ 5/60 6/60 16 15 0.501 0.504 19.1 17.8 65 140/100 _
63 70354 55 F SIMC SIMC _ _ 6/18 6/18 18 17 0.508 0.503 20.6 20.9 72 160/90 _
64 70364 60 F SIMC SIMC _ _ 5/60 6/36 12 12 0.516 0.522 14 13.6 90 110/70 _
65 70365 75 M SIMC SIMC _ _ 6/60 4/60 11 12 0.532 0.534 11.9 12.7 89 140/90 _
66 18444 58 F SMC SIMC _ _ CFCF 6/24 12 14 0.525 0.518 13.4 15.9 103 130/80 _
67 70360 55 F SIMC SIMC _ _ 6/24 6/36 14 14 0.534 0.534 14.7 14.7 98 120/80 _
68 72005 64 F SIMC SIMC _ _ 3/60 6/60 16 16 0.548 0.545 15.8 16 106 110/70 _
69 70347 70 F SIMC SIMC _ _ 6/60 6/60 13 14 0.485 0.485 17.2 18.2 72 170/100 _
70 70351 55 F SIMC SIMC _ _ 6/60 1/60 13 14 0.469 0.469 18.3 19.3 75 130/80 _
71 70354 70 M SIMC SIMC _ _ 2/60 6/36 11 11 0.534 0.528 11.7 12.2 80 130/90 _
72 70726 50 M SIMC SIMC _ _ 6/36 6/36 14 14 0.551 0.548 13.6 13.8 102 130/80 _
73 70747 70 F SIMC SIMC _ _ 1/60 4/60 14 13 0.484 0.485 18.3 17.2 81 160/100 _
74 70827 60 F SIMC SIMC _ _ 6/36 5/60 12 12 0.462 0.453 17.8 18.5 108 110/80 _
75 70177 50 M SIMC SIMC _ _ 2/60 4/60 16 16 0.502 0.504 19 18.8 140 170/110 _
76 70933 65 F SIMC SIMC _ _ 6/60 1/60 20 20 0.537 0.543 20.5 20.1 98 180/100 _
77 71024 59 M SIMC SIMC _ _ 6/36 6/24 20 21 0.578 0.584 17.7 18.3 128 120/80 _
78 71076 70 F SIMC SMC _ _ 6/60 CFCF 14 14 0.51 0.483 16.5 18.3 103 200/100 _
79 71273 65 F SIMC SIMC _ _ 4/60 5/60 12 12 0.492 0.485 15.7 16.2 83 120/80 _
80 71272 65 F SIMC SIMC _ _ 6/60 5/60 15 16 0.491 0.497 18.8 19.4 86 110/80 _
81 71276 70 F SIMC SIMC _ _ 5/60 6/36 10 10 0.483 0.485 14.3 14.2 78 110/80 _
82 17955 50 F SIMC SIMC _ _ 1/60 1/60 14 12 0.585 0.585 11.2 9.2 76 110/80 _
83 17988 74 M SIMC SIMC _ _ 6/24 6/36 14 10 0.522 0.523 15.6 11.5 112 140/90 _
84 17978 57 M SIMC SIMC _ _ 1/60 5/60 17 17 0.538 0.536 17.5 17.6 120 130/80 _
85 17846 76 M SIMC SIMC _ _ 2/60 6/36 14 13 0.505 0.508 16.8 15.6 135 140/80 _
86 17875 55 F SIMC SIMC _ _ 6/18 6/18 13 12 0.469 0.469 18.3 17.3 129 130/80 _
87 31575 60 F SMC SIMC _ _ HM 6/60 10 10 0.521 0.518 11.7 11.9 97 130/80 _
88 72009 68 M SIMC SIMC _ _ 6/24 6/24 13 13 0.518 0.524 14.9 14.5 93 130/80 _
89 72007 65 M SIMC SIMC _ _ 3/60 3/60 12 12 0.533 0.529 12.8 13.1 66 170/90 _
90 71994 60 M SIMC SIMC _ _ 3/60 6/36 10 11 0.503 0.512 13 13.3 50 140/90 _
91 72012 58 M SIMC SIMC _ _ 4/60 6/60 13 13 0.582 0.584 10.4 10.3 87 110/80 _
92 72008 52 F SIMC SIMC _ _ 6/24 6/60 16 16 0.534 0.526 16.7 17.3 95 120/80 _
93 71999 70 F SIMC SIMC _ _ 2/60 5/60 12 11 0.536 0.538 12.6 11.5 108 140/80 _
94 72003 65 F SIMC SIMC _ _ 3/60 6/36 8 10 0.436 0.468 15.6 15.4 103 200/100 _
95 72000 60 F SIMC SIMC _ _ 6/60 4/60 10 10 0.485 0.485 14.2 14.2 93 110/80 _
96 71998 68 F SIMC SIMC _ _ 6/36 6/60 13 13 0.436 0.436 20.6 20.6 82 160/90 _
97 72004 60 F SIMC SIMC _ _ 6/24 5/60 18 18 0.518 0.518 19.9 19.9 114 150/90 _
98 71995 60 F SIMC SIMC _ _ 2/60 4/60 10 8 0.469 0.485 15.3 12.2 77 140/90 _
99 71990 60 F SIMC SMC _ _ 4/60 HM 16 16 0.56 0.55 14.9 15.6 84 160/90 _
100 72006 60 F SIMC SIMC _ _ 3/60 2/60 14 15 0.534 0.534 14.7 15.7 92 100/80 _
101 12261 62 M SIMC SIMC + + 3/60 4/60 16 17 0.489 0.493 19.9 20.6 115 120/70 _
102 4305 75 M SMC SIMC + + HM 3/60 14 16 0.526 0.523 15.2 17.6 70 130/80 _
103 11311 66 F SIMC SIMC + + 4/60 5/60 14 14 0.453 0.453 20.5 20.5 101 110/70 _
104 10769 70 M SMC SMC + _ CFCF HM 13 13 0.453 0.453 19.5 19.5 106 130/80 _
105 1757 60 M SIMC SIMC + + 6/18 6/24 12 11 0.493 0.497 15.7 14.4 98 120/80 _
106 6681 60 F SIMC SIMC + + 6/24 3/60 12 12 0.519 0.518 13.2 13.4 105 110/70 _
107 6677 65 F SIMC SIMC + + 6/36 6/60 11 12 0.521 0.518 12.7 13.9 121 120/80 _
108 6526 61 M SIMC SIMC + + 3/60 6/24 10 12 0.498 0.5 13.3 15.1 123 130/80 _
109 10698 53 M SIMC SIMC + _ 6/60 HM 7 10 0.485 0.496 11.2 13.5 0.3 150/90 _
110 4285 65 F SIMC SIMC + + 4/60 2/60 10 10 0.485 0.485 14.2 14.2 88 120/80 _
111 4974 70 M SIMC SIMC + + 6/24 5/60 12 12 0.502 0.516 15 14.1 98 160/100 _
112 5044 56 M SIMC SMC _ + 6/36 1/60 14 14 0.492 0.485 17.7 18.2 126 100/80 _
113 3051 71 M SIMC SIMC + + 6/36 2/60 22 20 0.629 0.61 16.1 15.5 101 110/70 _
114 3075 67 M SIMC SIMC + _ 6/36 4/60 14 16 0.512 0.518 16.3 17.9 84 120/80 _
115 22236 70 F SIMC SIMC + + 3/60 6/60 14 14 0.497 0.481 17.4 18.4 76 110/80 _
116 22175 70 M SMC SIMC _ + HM 6/60 13 12 0.534 0.518 13.7 13.9 132 120/80 _
117 41645 65 M SIMC SIMC + + 5/60 1/60 13 14 0.485 0.51 17.2 16.5 112 110/80 _
118 67365 50 M SIMC SIMC + _ 2/60 2/60 10 10 0.502 0.486 13 14.2 106 110/70 _
119 67239 50 M SIMC SIMC _ + 3/60 6/60 10 10 0.468 0.468 15.4 15.4 106 150/60 _
120 68026 68 F SIMC SIMC _ + 6/18 2/60 18 18 0.554 0.534 17.4 18.7 112 150/90 _
121 68489 66 M SIMC SIMC + _ 4/60 6/18 9 10 0.534 0.535 9.7 10.7 140 120/80 _
122 68767 75 M SIMC SIMC + + 3/60 5/60 18 18 0.502 0.504 21 20.8 124 130/90 _
123 68773 65 F SIMC SIMC + + 6/24 6/36 16 16 0.476 0.472 20.8 20.1 131 150/90 _
124 68779 62 M SIMC SIMC _ + 6/60 3/60 13 14 0.58 0.571 10.6 12.2 133 120/80 _
125 69029 70 F SIMC SIMC + + 6/24 6/36 14 15 0.535 0.518 14.7 16.9 129 120/80 _
126 17812 67 F SIMC SIMC + + 6/24 6/18 18 18 0.542 0.548 18.2 17.8 102 110/70 _
127 70351 78 F SIMC SIMC + + 6/60 1/60 12 11 0.534 0.534 12.7 11.7 84 130/90 _
128 70347 70 F SIMC SIMC + + 5/60 2/60 10 10 0.523 0.518 11.5 11.9 78 120/80 _
129 70348 80 F SIMC SIMC + _ 2/60 2/60 10 10 0.485 0.485 14.2 14.2 75 120/90 _
130 17438 65 F SIMC SIMC _ + 6/60 4/60 10 10 0.453 0.469 16.5 15.3 98 100/70 _
131 70826 75 F SMC SIMC + + HM 1/60 17 17 0.534 0.534 17.7 17.7 134 140/80 _
132 71079 75 F SMC SIMC + + CFCF 3/60 18 18 0.524 0.534 19.5 18.7 74 180/100 _
133 70576 90 M SIMC SIMC + + 1/60 3/60 14 14 0.485 0.485 18.2 18.2 138 130/70 _
134 71075 65 F SIMC SIMC + + 6/36 6/36 10 10 0.436 0.436 17.6 17.6 94 130/80 _
135 71078 70 F SIMC SIMC + + 4/60 3/60 15 14 0.535 0.534 15.7 14.7 89 110/80 _
136 72011 50 M SIMC SIMC _ + 3/60 4/60 14 14 0.502 0.502 17 17 64 110/80 _
137 72007 55 M SIMC SIMC _ + 6/36 1/60 17 17 0.512 0.501 19.3 20.1 87 140/90 _
138 72027 50 M SIMC SIMC + + 2/60 5/60 13 14 0.502 0.502 16 17 72 110/70 _
139 71993 85 M SMC SMC + + HM 1/60 9 9 0.483 0.488 13.3 13 59 150/90 _
140 72235 72 F SIMC SIMC _ + 6/60 3/60 10 10 0.502 0.483 13 14.3 119 200/110 _
141 72108 65 M SIMC SIMC _ + 4/60 5/60 10 7 0.498 0.485 13.3 11.2 107 130/80 _
142 72106 55 M SIMC SIMC + + 3/60 6/36 14 14 0.507 0.507 16.7 16.7 82 120/80 _
143 18233 55 F SIMC SIMC + _ 6/60 6/60 15 16 0.469 0.485 20.3 20.2 88 120/80 _
144 72709 70 F SIMC SIMC + + 6/60 4/60 14 14 0.453 0.453 20.5 20.5 86 110/70 _
145 72713 70 F SIMC SIMC _ + 3/60 2/60 14 14 0.469 0.469 19.3 19.3 67 100/60 _
146 72715 50 M SIMC SIMC + + 6/36 6/36 11 10 0.502 0.504 14 12.9 102 100/60 _
147 72721 65 F SIMC SIMC + _ 6/60 4/60 12 11 0.469 0.453 17.3 17.5 99 120/80 _
148 72714 70 M SIMC SIMC + _ 1/60 2/60 16 16 0.485 0.496 20.2 19.5 122 120/80 _
149 73346 72 M SIMC SIMC + + 6/60 4/60 12 12 0.453 0.453 18.5 18.5 96 110/80 _
150 73701 75 F SMC SIMC + + HM 3/60 12 11 0.469 0.472 17.3 16.1 78 100/60 _
